Redhill Biopharma Ltd (NASDAQ:RDHL)

Delayed Data
As of Apr 20
 +0.08 / +1.62%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 20.00, with a high estimate of 51.42 and a low estimate of 17.00. The median estimate represents a +299.20% increase from the last price of 5.01.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.52%
Growthannually 30.77%


Growthquarterly 1.82%
Growthannually 207.49%
Key to the earnings and sales forecast charts.